Medical cosmetology, referred to as medical cosmetology for short, refers to a cosmetic method that uses traumatic or irreversible medical technologies such as drugs, surgery and medical devices to repair and reshape people's appearance and various parts of the human body. Next, let's take a look at the top ten leading stocks in the medical beauty industry: 1. Introduction to Aimeike: the leader in the medical beauty industry, the first enterprise in China to obtain the registration certificate of related products and medical devices. Products: solution injection products, gel injection products, facial implants, cosmetics. Valuation: the total market value is 123.67 billion, the P/B ratio is 23.31, and the price-earnings ratio of TTM is 115.89, which is 66% lower than the historical time. The valuation is moderate. 2. Introduction to West China Biology: the main products of bioactive substances such as hyaluronic acid and the end products of biomedical materials. Products: hyaluronic acid raw materials (excluding derivatives), medical terminal products-injection products, functional skin care products-disposable stock solution. Valuation: The total market value is 7.71 billion, the P/B ratio is 11.64, and the TTM P/E ratio is 85.23, which is 76% lower than the historical time and the valuation is low. 3. Brief introduction of Aoyuan Meigu: A-level medical beauty institution certified by China Plastic Surgery Association, whose main business is fiber new material business and medical beauty business. Products: viscose series, real estate sales, medical beauty services. Valuation: The total market value is 5.73 billion yuan, and the P/B ratio is 4.11. TTM P/E ratio is at a loss, which is 27% lower than the historical time, and the valuation is on the high side. 4. Introduction of East China Medicine: The medical and beauty industry focuses on non-surgical mainstream medical and beauty products such as facial fillers, body shaping, catgut embedding and energy devices. Products: Chinese and western medicine, medical equipment, differentiated sodium hyaluronate, collagen stimulator, botulinum toxin A, implant line, energy equipment. Valuation: The total market value is 74.68 billion, the P/B ratio is 4.3, and the TTM P/E ratio is 31.89, which is 38% lower than the historical time. The valuation is moderate. 5. Brief introduction of Haohai Ministry of Health: a high-tech biomedical enterprise focusing on research, development, production and sales of medical biomaterials. Products: ophthalmic products, medical beauty and wound care products, anti-adhesion and hemostasis products. Valuation: The total market value is 14.64 billion, the P/B ratio is 2.63, and the TTM P/E ratio is 46.3, which is 87% lower than the historical time and the valuation is low. 6. Ogilvy & Mather Medical Products Company Profile: There are few enterprises with complete industrial chain in the field of disposable medical consumables such as medical dressings. Products: The company's products cover five series: wound care, surgery, infection prevention, medical combination bag and home care, and some products are used in advanced fields such as neurosurgery. Valuation: The total market value is 7.726 billion, the P/B ratio is 2.66, and the TTM P/E ratio is 16.35, which is 87% lower than the historical time and the valuation is low. 7. Introduction of Langzi shares: The company holds three major domestic medical beauty brands: Milan Berrillo, Pure Skin Medical Beauty and Gaoyisheng Medical Beauty, and strategically invests in DMG, a famous Korean medical beauty service group. Products: women's coats, women's trousers, women's skirts, women's coats, baby clothes, baby products, surgical medical beauty, non-surgical medical beauty, consulting services. Valuation: The total market value is 13.34 billion, the P/B ratio is 4.54, and the TTM P/E ratio is 128.99, which is 25% lower than the historical time and the valuation is on the high side. 8. Introduction of Paofanni (female name): Kunming Weinuo, a subsidiary of the company, is mainly engaged in medical beauty services, including laser, microneedle and other beauty services. Products: skin care products such as cream, skin care lotion, mask, essence, and fierce lotion, and makeup products such as cream, BB cream, and makeup remover. Valuation: The total market value is 78.11 billion, the P/B ratio is 15.94, and the TTM P/E ratio is 83.96, which is 9% lower than the historical time, and the valuation is extremely low. 9. Brief introduction of Shuiyang shares: HPH is a brand of light medical beauty newly launched by the company. At present, it is mainly sold in Tmall, Ji Yun and other channels, and its operating entity is Yu Jiahui Holding Company. Products: facial mask, water cream, make-up, personal care, cleaning and other cosmetics. Valuation: The total market value is 6.619 billion, the P/B ratio is 3.9, and the TTM P/E ratio is 28.74, which is 8% lower than the historical time and the valuation is low. 1. Introduction to Fang La's naturalization: The company's main business is washing, skin care and make-up products. Products: face cream, hair conditioner, shower gel, shampoo, soap, gel water and gel cream. Valuation: total market value is 3.3 billion.